your market intelligence analyst
Search Results
219 results
Your search is now limited to «Johnson & Johnson» expert search.
ENDPOINTS 08/14/2019 07:12
Eli Lilly has come out swinging at J&J, staking out its challenger position in a crowded battle of plaque psoriasis blockbusters.
More from ENDPOINTS:
BioPharma Dive 08/13/2019 12:04
A study of psoriasis patients found Lilly's Taltz outperformed J&J's Tremfya, which works the same way as AbbVie's new-to-market offering, Skyrizi.
More from BioPharma Dive:
Benzinga 08/13/2019 11:40
Eli Lilly And Co (NYSE: ) reported positive data for its plaque psoriasis drug Tuesday in a head-to-head comparison study with Johnson & Johnson (NYSE: )'s Janssen unit's Tremfya. What Happened. said Tuesday ahead of the market open that Talz, a monoclonal antibody that selectively binds with interleukin 17A (IL-17A) cytokine, met the primary and all major secondary endpoints up to 12 weeks in the Phase 4 IXORA-R study. Taltz has been approved for treating adults with moderate to severe plaque psoriasis ...
More from Benzinga:
FiercePharmaManufacturing 08/13/2019 10:34
Tuesday, Eli Lilly said Taltz had topped the J&J med at achieving total skin clearance in psoriasis patients after 12 weeks of treatment.
More from FiercePharmaManufacturing:
ETHealthWorld (India) 08/08/2019 12:39
We are paying everyone," Johnson and Johnson told the court.
More from ETHealthWorld (India):
pharmaphorum 08/07/2019 06:00
Trials of the J&J/Bavarian Nordic vaccine were also placed on hold because of the dwindling number of Ebola cases as the last major outbreak petered away.
More from pharmaphorum:
Insurance Journal 08/06/2019 01:54
Kentucky Jury Rejects Talc Powder Asbestos Claims Against J&J, Colgate.
More from Insurance Journal:
Top Class Actions 08/03/2019 13:19
According to a July 22, 2019, Law360 report, a trained expert in consumer behavior was called to the stand in week two of the Superior Court of California bench trial against Johnson & Johnson... .
More from Top Class Actions:
Investing News Network 07/31/2019 08:44
CB2 Insights (CSE:CBII; OTCQB:CBIIF) ("CB2" or the "Company"), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, has appointed former Johnson & Johnson executive Peter Cummins as a Director to its Board, increasing the size of its Board of Directors to seven (7) members. . 07/29/2019 21:41
WASHINGTON (Reuters) - The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in June as part of an investigation into whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday.
More from

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications